PetMed Express (NASDAQ:PETS) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?

PetMed Express, Inc. (NASDAQ:PETS)’s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.85 and traded as high as $3.30. PetMed Express shares last traded at $3.23, with a volume of 92,397 shares trading hands.

Analysts Set New Price Targets

A number of equities research analysts have commented on PETS shares. Wall Street Zen downgraded PetMed Express from a “hold” rating to a “sell” rating in a report on Saturday, October 18th. Weiss Ratings reiterated a “sell (e+)” rating on shares of PetMed Express in a research note on Monday, December 29th. One analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Sell” and an average target price of $3.20.

PetMed Express Price Performance

The firm has a market cap of $69.03 million, a PE ratio of -1.22 and a beta of 0.65. The business has a 50-day moving average price of $2.90 and a two-hundred day moving average price of $2.85.

Institutional Investors Weigh In On PetMed Express

Institutional investors and hedge funds have recently bought and sold shares of the stock. R Squared Ltd purchased a new position in PetMed Express during the second quarter worth $34,000. Occudo Quantitative Strategies LP acquired a new stake in shares of PetMed Express during the second quarter valued at $51,000. Oxford Asset Management LLP purchased a new stake in PetMed Express during the 2nd quarter worth about $55,000. CIBC Private Wealth Group LLC acquired a new position in PetMed Express in the 3rd quarter valued at about $75,000. Finally, Bridgeway Capital Management LLC lifted its holdings in PetMed Express by 96.2% in the 2nd quarter. Bridgeway Capital Management LLC now owns 40,800 shares of the company’s stock valued at $135,000 after purchasing an additional 20,000 shares in the last quarter. Hedge funds and other institutional investors own 73.33% of the company’s stock.

PetMed Express Company Profile

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.